Cumberland Pharmaceuticals (CPIX) Total Liabilities (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Total Liabilities data on file, last reported at $49.7 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 19.47% year-over-year to $49.7 million; the trailing twelve-month figure through Mar 2026 stood at $49.7 million (up 19.47% YoY), and the FY2025 full-year result was $52.3 million, down 1.43% from the prior year.
• Total Liabilities retreated to $49.7 million in Q1 2026, from $52.3 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $57.0 million in Q4 2022 to a low of $40.1 million in Q3 2025.
• A 5-year average of $50.9 million and a median of $52.5 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 36.06% in 2022 and slipped 23.43% in 2025, its largest moves.
• Tracing CPIX's Total Liabilities over 5 years: stood at $57.0 million in 2022, then slipped by 7.79% to $52.5 million in 2023, then advanced by 0.99% to $53.0 million in 2024, then dropped by 1.43% to $52.3 million in 2025, then slipped by 4.95% to $49.7 million in 2026.
• Business Quant data shows CPIX's Total Liabilities at $49.7 million in Q1 2026, $52.3 million in Q4 2025, and $40.1 million in Q3 2025.